Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The December issue includes Reviews on fatty acid oxidation in skeletal muscle, stress kinases in metabolic disease and determining HbA1c targets for diabetes mellitus, as well as a Perspective on circadian rhythms and the gut microbiota.
Image: Dermal adipocyte staining in the skin of a 35-day-old ‘adipochaser’ mouse. Image supplied by Zhuzhen Zhang and Philipp Scherer, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, USA. Cover design: Jennie Vallis.
A need exists for rapid, cheap and noninvasive diagnostic tests for type 2 diabetes mellitus (T2DM). Now, a smartphone-based photoplethysmography screening test has been reported to detect T2DM based on a novel digital vascular biomarker, distinct from blood glucose, analysed with deep learning.
This Review summarizes the adaptations to lipid metabolism that occur in skeletal muscle in response to either a high-fat diet or exercise training. In addition, obesity-associated impairments in fatty acid oxidation capacity and the importance of exercise for overcoming lipid metabolic inflexibility in obesity are discussed.
Obesity activates stress-activated protein kinases (SAPKs), such as the p38 and JNK stress kinases, in several tissues, including adipose, liver, skeletal muscle, immune organs and the central nervous system. This Review discusses the role of SAPKs in metabolic control and highlights important discoveries in the field.
This Review highlights the landmark T1DM and T2DM trials that inform the current guidelines for HbA1c targets, which remain contentious. In addition, the Review discusses individualized HbA1c targets, examines the limitations of HbA1c and considers alternatives for monitoring glycaemic control.
Disruption of the circadian system can alter microbiome communities and can perturb host metabolism leading to the metabolic syndrome. This Perspective discusses the role of intestinal microbiota in mediating the effects circadian dysrhythmia on human health.